Radiopharmacy —
Training activity: 2

Details

Compare and contrast cell labelling methods for red and white blood cells. Critique the SOPs

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

• Principles of cell labelling methods
• National legislation and guidance
• Nuclear medicine protocols
• Handling requirements
• Product segregation
• Cleaning requirements for blood products
• Dispatch requirements for blood products
• Labelling efficiency
• Health and safety, including working with biological hazards
• Incident reporting
• Waste management

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

• What are the specific objectives of this DTA as outlined in your training plan or discussed with your training officer?
• What are the fundamental principles behind red and white blood cell labelling?
• What are the key differences and similarities in the methodologies used for labelling these cell types?
• What Standard Operating Procedures (SOPs) are relevant to this activity? Have you reviewed them thoroughly?
• What are the potential critical steps and quality control measures involved in each method?
• What specific insights do you hope to gain about the strengths and weaknesses of different cell labelling techniques?
• How will you improve your ability to critically evaluate scientific methodologies?
• Will you review relevant literature or guidelines on cell labelling methods?
• Will you prepare specific questions to ask during the activity based on your initial understanding of the different methods?
• Have you considered potential challenges you might face when comparing and contrasting the methods ? How might you address these?

In action

• Pay attention to your actions as you compare and contrast the cell labelling methods. How are you approaching the comparison (e.g., focusing on specific steps, reagents, quality control)? Why are you undertaking the critique of the Standard Operating Procedures (SOPs) in this particular way (e.g., focusing on clarity, safety, efficiency)? What decisions are you making as you analyse the different methods and the SOPs? For example, are you deciding which criteria are most important for the comparison, or which aspects of the SOPs require the most scrutiny? What aspects of comparing and contrasting the methods or critiquing the SOPs feel intuitive based on your current knowledge, and what requires more conscious effort and reference to materials?
• How effective are your actions in identifying the similarities and differences between the cell labelling methods and in formulating your critique of the SOPs? What challenges are you facing as you perform this activity? For instance, are you finding it difficult to access relevant information, understand specific technical details, or formulate constructive criticism? What can you learn about cell labelling methods and the development of SOPs as this activity unfolds? How does comparing these methods and critiquing the SOPs connect to your existing knowledge and skills in radiopharmacy or quality assurance?
• Are there alternative approaches you could be considering for comparing the methods or critiquing the SOPs (e.g., focusing on different aspects, using different analytical techniques)? What support or guidance might you need in this moment, such as clarification on a specific procedure or feedback on your critique? Are you ensuring your critique remains within the scope of your understanding of radiopharmacy practice and quality management systems?

On action

• What were the key differences and similarities you observed between the cell labelling methods for red and white blood cells? What specific aspects of the Standard Operating Procedures (SOPs) did you focus on during your critique?
• What specific aspects of the methods did you focus on in your comparison?
• What new insights did you gain about the principles and practicalities of red and white blood cell labelling? Did your critique identify any strengths or weaknesses in the current SOPs? What were they? Were there any unexpected challenges or points of interest that arose while comparing the methods and critiquing the SOPs? What did you learn from these? How did this activity enhance your understanding of the production and quality assurance of radiopharmaceuticals?
• What specific areas related to cell labelling methods would you like to explore further? How might the insights gained from comparing these methods influence your approach to reviewing other processes   in the future? What actions or ‘next steps’ will you take to assimilate what you have learned about cell labelling  critique? Do you require any support or resources to further develop your understanding in these areas?

Beyond action

1. Have you reviewed your critique of the Standard Operating Procedures (SOPs) in light of any changes or updates to these procedures, or through observing different practices? Have you discussed your understanding of cell labelling methods with peers or colleagues, and has this changed your perspective?
2. How has your understanding of the similarities and differences in cell labelling methods informed your approach to preparing other radiopharmaceuticals or blood products?  Have you identified any observable behaviours or practices related to cell labelling that you have assimilated into your own practice since this DTA?
3. How might your understanding of different cell labelling techniques and inform your approach to new products/processes in radiopharmacy? Will your experience in critiquing SOPs assist you in future quality improvement initiatives or when contributing to the development of new procedures? What transferable skills, such as critical analysis, did you develop through this activity that will be valuable in your ongoing professional development?

Relevant learning outcomes

#	Outcome
# 2	Outcome Plan and manage preparation sessions for a range of diagnostic and therapeutic radiopharmaceuticals.
# 3	Outcome Critically appraise procedures and practices relating to the production and quality assurance of radiopharmaceuticals.